Insider Selling: Rocket Pharmaceuticals (NASDAQ:RCKT) General Counsel Sells $11,806.34 in StockMarket Beat·Aug 17 at 06:23 PMRCKT+7.08%
Rocket Pharmaceuticals (NASDAQ:RCKT) Upgraded by Wall Street Zen to "Hold" RatingMarket Beat·Aug 17 at 12:06 AMRCKT+7.08%
Insider Selling: Rocket Pharmaceuticals (NASDAQ:RCKT) Insider Sells $16,453.50 in StockMarket Beat·Aug 13 at 04:22 PMRCKT+7.08%
Rocket Pharmaceuticals Announces Positive Clinical Safety Update from Initial Three Patients Treated with RP-A501 Under Modified Phase 2 Protocol for Danon Disease | RCKT Stock NewsStockTitan·Aug 2 at 10:00 PMRCKT+7.08%
Rocket Pharmaceuticals (NASDAQ:RCKT) Raised to Hold at Wall Street ZenMarket Beat·Aug 1 at 12:48 AMRCKT+7.08%
Rocket Pharmaceuticals (RCKT) to Release Quarterly Earnings on ThursdayMarket Beat·Jul 30 at 04:26 AMRCKT+7.08%GS-A-0.42%
